The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.

NCT Number	NCT07250100
Lead Sponsor	Herlev Hospital Collaborators: Danish Cancer Society
Conditions	Pancreatic Cancer, Microbiome
Enrollment	300 participants
Start Date	2025-11-01
Primary Completion	2030-10 (estimated)
Study Completion	2037-12 (estimated)
Updated on ClinicalTrials.gov	2025-11-26